Bottom line
How much do JDOC and JEHSX overlap?
58% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 52.2% of JDOC's assets and 50.4% of JEHSX's. They share a meaningful core but differ in the rest of the portfolio.
JEHSX holds far more positions (173 vs 61), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings JDOC and JEHSX have in common
| Holding | % of JDOC | % of JEHSX | Overlap |
|---|---|---|---|
| AbbVie, Inc. | 7.85% | 5.28% | 5.28% |
| Eli Lilly & Co. | 7.76% | 14.30% | 7.76% |
| UnitedHealth Group, Inc. | 5.85% | 5.95% | 5.85% |
| Merck & Co., Inc. | 4.82% | 4.21% | 4.21% |
| Johnson & Johnson | 4.82% | 6.33% | 4.82% |
| Thermo Fisher Scientific, Inc. | 3.73% | 2.67% | 2.67% |
| Bristol-Myers Squibb Co. | 3.57% | 2.22% | 2.22% |
| Abbott Laboratories | 3.11% | 2.00% | 2.00% |
| CVS Health Corp. | 2.83% | 0.98% | 0.98% |
| Stryker Corp. | 2.23% | 1.87% | 1.87% |
| Danaher Corp. | 2.16% | 1.51% | 1.51% |
| Intuitive Surgical, Inc. | 1.93% | 1.98% | 1.93% |
| Cardinal Health, Inc. | 1.51% | 1.09% | 1.09% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in JDOC
- AstraZeneca plc — 3.76%
- Roche Holding AG — 2.82%
- Novo Nordisk A/S — 2.61%
- GSK plc — 2.47%
- Cencora, Inc. — 2.07%
- Argenx SE — 2.06%
- Edwards Lifesciences Corp. — 1.73%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Regeneron Pharmaceuticals, Inc. — 1.60%
- Novartis AG — 1.60%
- Biogen, Inc. — 1.56%
Only in JEHSX
- Gilead Sciences Inc. — 2.95%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Amgen Inc. — 1.90%
- Elevance Health Inc. — 1.63%
- Natera Inc. — 1.49%
- Guardant Health Inc. — 1.28%
- Royalty Pharma plc — 1.02%
- Tenet Healthcare Corporation — 0.99%
- Kymera Therapeutics Inc. — 0.93%
- Protagonist Therapeutics Inc. — 0.90%
- BrightSpring Health Services Inc. — 0.88%
- Moderna Inc. — 0.87%
Asset mix
| Asset type | JDOC | JEHSX |
|---|---|---|
| Stocks | 99.2% | 99.0% |
| Cash & short-term funds | — | 0.9% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | JDOC | JEHSX |
|---|---|---|
| US | 75.2% | 95.0% |
| GB | 6.2% | 0.8% |
| CH | 4.4% | 0.3% |
| DK | 4.0% | 0.7% |
| JP | 2.5% | 0.5% |
| NL | 2.4% | 1.0% |
| DE | 1.9% | 0.2% |
| IL | 1.6% | 0.2% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do JDOC and JEHSX overlap?
What stocks do JDOC and JEHSX have in common?
Should I own both JDOC and JEHSX?
Which holds more stocks, JDOC or JEHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.